Figure 11 — Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)

Research Paper|Volume 11, Issue 8|pp. 2202–2216

Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)

Back to articleFigure 11(11 of 16)

100%

Figure 11.Direct side-by-side metabolic comparison of low-dose Vitamin C with the DAV triple combination: Seahorse profiles. Note that low-dose Vitamin C increases oxidative mitochondrial metabolism, while the DAV triple combination results in severe ATP depletion. Also, note that low-dose Vitamin C and the DAV triple combination both increase glycolysis.